Epredia and Mindpeak Announce Distribution Agreement for AI-Based Image Recognition Software As cancer cases rise and diagnostic processes become more complex, pathology laboratories face increasing pressure to speed up processes…
DECA Dental Group Adopts Pearl’s AI to Improve Clinical Outcomes and Patient Engagement In the rapidly evolving landscape of dental technology, the integration of artificial intelligence (AI) is becoming a…
Expanding Access to Personalized Radiation Therapy for Prostate Cancer Patients Why do more than 20% of prostate cancer patients experience persistent urinary side effects after radiation therapy? MiraDx, a molecular…
BXLS and Johnson & Johnson Collaborate to Fund Bleximenib Clinical Trials for AML Why is the development of new treatments for acute myeloid leukemia (AML) so critical? Despite being the…
Positive Top-Line Results for Reblozyl in Alpha-Thalassemia Study Is the treatment landscape for alpha-thalassemia about to change? Bristol Myers Squibb has announced positive top-line results from an ongoing, ex-US, Phase 2 registrational…
Gilead Sciences Seals $7.8 Billion Deal for Arcellx to Boost CAR T-Cell Therapy In the rapidly evolving landscape of cancer immunotherapies, where breakthroughs are crucial for patient outcomes, Gilead Sciences, Inc. has…
Exact Sciences Corporation Gains Overwhelming Shareholder Support for Abbott Deal In the rapidly evolving landscape of cancer diagnostics, where precision and speed are paramount, Exact Sciences Corporation has taken a…
GekkoVet and Royal Canin Enter Latin America with Mexico Launch, Opening a New Continent in their Global Partnership GekkoVet, the Finnish leader in AI-powered clinical decision support for veterinarians, and…
SullivanCotter Welcomes Devin Paullin as Senior Vice President of Strategic Business Partners SullivanCotter, the nation’s leading independent consulting firm in the assessment and development of total rewards programs, workforce solutions,…
Positive Phase 3 Data Demonstrate Potential for ENTYVIO® (vedolizumab) to Address Treatment Gap for Children and Adolescents with Moderate to Severe Ulcerative Colitis Takeda today announced positive data from the pivotal Phase 3…
M-Cube and SOLUM Enter Strategic Partnership to Deliver Integrated Digital Signage and ESL Solutions for Retail Across Europe M-Cube and SOLUM have entered into a strategic partnership through a Memorandum of Understanding (MoU)…
ViiV Healthcare’s long-acting Cabenuva (cabotegravir + rilpivirine) for HIV demonstrates superior efficacy compared to daily oral therapy for people with adherence challenges; results published in NEJM ViiV Healthcare, the global specialist HIV company…